Financials
- Market Capitalization 2.62 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.71
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1782 | ATAI AtaiBeckley Inc. - Common Stock | 7.42 USD | +0.95% | +0.27% | +3.63% | +87.85% | 2.75 B USD | ||
| 1812 | NRIX Nurix Therapeutics, Inc. - Common stock | 25.43 USD | -1.51% | -6.47% | +7.30% | +126.85% | 2.64 B USD | ||
| 1824 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 10.03 USD | -1.38% | +3.40% | +13.72% | +21.28% | 2.56 B USD | ||
| 1828 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 35.48 USD | -0.50% | +3.50% | +8.50% | +19.30% | 2.56 B USD |